Fast-track Diagnosis for Lung Cancer Suspects With PET-CT and EUS
NCT00556647 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 297
Last updated 2013-04-08
Summary
Patients who are admitted to the outpatient pulmonology department by a general practitioner or specialist with a chest X-ray suspicious for lung cancer with an age between 18 and 80 years are suitable for participation. The X-ray and referral are studied by a chest physician (by phone or fax ). Selected patients are invited to enter the study after answering a questionnaire by phone (p. 31). The questionnaire screens patients' interest, co-morbidity and medication use. Informed consent forms, patient information forms and a time table for the diagnostic day are provided by mail or E-mail in cases where time gets short. Waiting time to enter the study will be no longer than one week.
Hundred patients will be recruited by means of informed consent. Patients will be admitted at the pulmonary ward for the study day and will be accompanied by nurses. All patients will get PET-CT scanning in the morning of the study day. Depending on the location of lesions seen on PET-CT, further invasive diagnostic procedures will be planned for the afternoon.
Mediastinal and adjacent structures will be analysed with EUS-FNA. Mediastinal staging will be done with bronchoscopy alone for central located tumors, peripherally located lesions will be analysed with EUS-FNA or bronchoscopy.
The percentage of patients in which this diagnostic track leads to a diagnosis and tumor stage in one day will be determined. The number of tests and diagnostic procedures needed to obtain a diagnosis, including tumor stage (especially final stage NSCLC) and function tests, will be compared with a historical matched study group. This historical study group is chosen from an era before the availability of integrated PET-CT and ultrasound guided endoscopic tools and meets the same inclusion and exclusion criteria as the patients in this study. The timelines from initial chest X-ray to diagnostic day to informing the patient to start of treatment will be determined. These figures will be compared with the historical study group.
Conditions
Interventions
- PROCEDURE
-
fast track diagnosis
fast-track diagnosis, PET-CT, bronchoscopy
- PROCEDURE
-
conventional diagnosis
out-patient diagnosis
Sponsors & Collaborators
-
Isala
lead OTHER
Principal Investigators
-
J. Stigt, Drs. · Isala
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-09-30
- Primary Completion
- 2010-01-31
- Completion
- 2010-01-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT
NCT01261585 ·Status: COMPLETED
-
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients
NCT04678440 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dual PET/CT Imaging in Lung Cancer
NCT01539928 ·Status: UNKNOWN
-
Using FDG-PET During Radiation Therapy in Non-Small Cell Lung Cancer
NCT01190527 ·Status: COMPLETED ·Phase: NA
-
PET CT Re-Planning NSCLC (4DCT-PET)
NCT03403127 ·Status: COMPLETED ·Phase: NA
-
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy
NCT00424138 ·Status: TERMINATED ·Phase: NA
-
Parametric Imaging in Positron Emission Tomography for Patient With Lung Cancer
NCT02821936 ·Status: COMPLETED ·Phase: NA
-
Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI
NCT01525056 ·Status: COMPLETED ·Phase: PHASE2
-
18FDG PET for Early Identification of Tumor Exhaust for Immunotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Bronchopulmonary Carcinoma or Melanoma
NCT03584334 ·Status: COMPLETED ·Phase: NA
-
An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer
NCT05558904 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The Use of Breathing Synchronized PET/CT Imaging In the Detection and Quantification of FDG Uptake in Lung Nodules
NCT00598065 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography (PET)/Computed Tomography (CT) and Roentgen in Lung Cancer: Evaluation of Patients in General Practice
NCT00675168 ·Status: UNKNOWN ·Phase: PHASE4
-
Use of [18]F-FDG on PET/CT as an Alternative Non-invasive Method for Staging of Lung Cancer
NCT02664792 ·Status: COMPLETED ·Phase: NA
-
PET-CT Predicting Lymph Nodes Metastasis
NCT05970913 ·Status: ACTIVE_NOT_RECRUITING
-
68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.
NCT06608160 ·Status: RECRUITING
-
Use of Integrated PET/CT as a First Line Staging and Re-staging Technique in Oncologic Patient.
NCT06168877 ·Status: COMPLETED
-
Low Dose Chest Computed Tomography (CT) Screening
NCT01180010 ·Status: COMPLETED
-
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
NCT04588064 ·Status: COMPLETED ·Phase: NA
-
PD-L1 PET Imaging in Melanoma Patients
NCT03520634 ·Status: COMPLETED ·Phase: NA
-
Added Value of PET/CT in Lung Cancer
NCT06494800 ·Status: NOT_YET_RECRUITING
-
Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)
NCT00136864 ·Status: COMPLETED ·Phase: PHASE3
-
Predictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year Survival
NCT01261598 ·Status: COMPLETED ·Phase: NA
-
Pembrolizumab-PET Imaging
NCT02760225 ·Status: COMPLETED ·Phase: NA
-
PET/CT-Based Image Analysis and Machine Learning of Hypermetabolic Pulmonary Lesions
NCT06602674 ·Status: COMPLETED
-
Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation
NCT00522639 ·Status: TERMINATED ·Phase: PHASE3